Af Nina Flindt Temte
Læge Charlotte Kærgaard Sonne deltog fra den 25-28. februar med en mundtlig præsentation i konferencen "World Psychiatric Association's Thematic Congress, Innovation in Psychiatry: Effective Interventions for Health and Society (WPATC)" i Melburne, Australien. Læs mere om konfererencen: https://wpamelbourne.kenes.com/
Charlottes præsentation havde titlen "The MindSpring group programme – a mixed-method study". Se abstract nedenfor.
Ud fra abstractet var Charlotte en af de 12 dygtige deltagere ud af i alt 322 ansøgere, som fik tildelt et WPA Early Career Fellowship. Med dette fellowship fik Charlotte, udover den store ære og anerkendelse, støtte til udgifter knyttet til WPATC-konferencen samt deltog i konferencen som særligt inviteret taler.
Charlotte Kærgaard Sonne sammen med WPA (World Psychiatric Association) formand, Professor Helen Herrman til slutceremonien, hvor der blev uddelt diplomer til de 12 fellowship modtagere.
The MindSpring group programme – a mixed-method study
Background and aim: Psychological symptoms are common among refugees and often impact their wellbeing significantly. MindSpring is a group intervention for refugees with the purpose of strengthening the participants' ability to cope with psychosocial problems, thereby preventing that premigration trauma and postmigratory stressors evolve into psychiatric disorders. It consists of eight two-hour sessions, and groups are facilitated by a trainer with refugee background.
Although psychosocial interventions for newly arrived refugees are implemented in many countries, very few studies exist on such programmes. The aim of the present project was therefore to study the acceptability and effects of MindSpring.
Methods: The study was a mixed-method observational study with approximately 70 newly arrived refugees from Arabic speaking countries who completed the MindSpring programme. Participants completed a brief demographic questionnaire at baseline as well a questionnaire about outcome upon evaluation. Furthermore participants completed the WHO-5 wellbeing questionnaire (which is also validated as a depression screening tool) before and after the intervention. Post-treatment focus groups were undertaken with approximately 30 participants.